Page last updated: 2024-10-31

mitoxantrone and Cancer of Muscle

mitoxantrone has been researched along with Cancer of Muscle in 2 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kishimoto, TE1
Yashima, S1
Nakahira, R1
Onozawa, E1
Azakami, D1
Ujike, M1
Ochiai, K1
Ishiwata, T1
Takahashi, K1
Michishita, M1
Luraschi, A1
Saglietti, G1
Ferrari, V1
Fedeli, P1
Ripamonti, G1
Gioria, A1
Bersi, M1

Other Studies

2 other studies available for mitoxantrone and Cancer of Muscle

ArticleYear
Identification of tumor-initiating cells derived from two canine rhabdomyosarcoma cell lines.
    The Journal of veterinary medical science, 2017, Jul-07, Volume: 79, Issue:7

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Dog Diseases; Dogs; Doxorubicin; Drug Resistance,

2017
[Primary extranodal non-Hodgkin's lymphoma of muscle tissue].
    Recenti progressi in medicina, 1997, Volume: 88, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Extremities; Female; Follow-

1997